Your browser doesn't support javascript.
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Goldman, Serge, Bron, Dominique, Tousseyn, Thomas, Vierasu, Irina, Dewispelaere, Laurent, Heimann, Pierre, Cogan, Elie, Goldman, Michel.
Frontiers in medicine ; 8, 2021.
Article in English | EuropePMC | ID: covidwho-1564176
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.
Search on Google
Print
XML
Collection: Databases of international organizations Database: EuropePMC Type of study: Case report Topics: Vaccines Language: English Journal: Frontiers in medicine Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Search on Google
Print
XML
Collection: Databases of international organizations Database: EuropePMC Type of study: Case report Topics: Vaccines Language: English Journal: Frontiers in medicine Year: 2021 Document Type: Article